Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pharmaids Pharmaceuticals Ltd has informed BSE that its Board of Directors meeting is scheduled for May 29, 2026. The meeting will consider and approve the Audited Financial Results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. Additionally, the company announced that the Trading Window will remain closed for Designated Persons and their immediate relatives until 48 hours after the results are declared. This is a standard regulatory intimation under SEBI Listing Regulations and does not contain any actual financial figures or results at this stage.
This is a routine procedural filing announcing a future board meeting. No impact on shareholders can be assessed until actual financial results are disclosed. The trading window closure is standard practice ahead of earnings announcements.